|
www.Xtremepicks.Com: Xtremepicks Alerts October 28, 2009 : LMIA, MDSO, IART and IGOI
(M2 PressWIRE Via Acquire Media NewsEdge) Xtremepicks.com Alerts include LMI Aerospace, Inc. (Nasdaq: LMIA), Medidata Solutions (NASDAQ: MDSO), Integra LifeSciences Holdings Corporation (Nasdaq: IART) and iGo, Inc. (Nasdaq: IGOI)
LMI Aerospace, Inc. (Nasdaq:LMIA) trading at $10.77 per share on trading volume of 112,927 shares.
In a press release out on October 28, LMI Aerospace Announces a Conference Call to Discuss 2009 Third Quarter Results
Call to be Morning of Friday, November 6, 2009
ST. LOUIS, Oct 28, 2009 -- LMI Aerospace, Inc. (Nasdaq:LMIA), a leading provider of design engineering services, structural components, assemblies, kits and structural components to kits to the aerospace, defense and technology industries, plans to release its third quarter results just prior to the market open on Friday, November 6, 2009. A conference call to discuss the results will follow shortly thereafter.
LMI Aerospace, Inc. is a provider of design engineering services, structural assemblies, kits and components to the aerospace, defense and technology markets. The Company provides an array of manufacturing capabilities and value-added services to the commercial, corporate, regional and military aircraft and technology markets. LMI Aerospace is a supplier to aircraft original equipment manufacturers (OEMs) and Tier 1 aerospace suppliers. In addition to aerospace products, the Company produces components and assemblies for laser equipment used by semiconductor and medical equipment manufacturers in the technology industry. It also provides prototyping and design capabilities to customers to support new product development. The Company operates in two business segments: Aerostructures segment and Engineering Services. In January 2009, it acquired Integrated Technologies, Inc. (Intec).
Medidata Solutions (NASDAQ: MDSO) trading at $16.04 per share on trading volume of 13,260 shares.
In a press release out on October 28, Omnicare Clinical Research Earns Highest Accreditation in Medidata Solutions CRO Program
Global CRO Broadens EDC-Related Services for Sponsors through Medidata ASPire to Win Program
NEW YORK, Oct 28, 2009 -- Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that global contract research organization (CRO) Omnicare Clinical Research has attained Rave Accredited Plus, the most advanced level in Medidata's ASPire to Win(R) program for CROs and other service providers. With this accreditation, Omnicare Clinical Research can now offer sponsors a comprehensive suite of Medidata Rave(R) services that will enable them to cost-effectively increase clinical research efficiencies across all therapeutic areas and trial phases.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer(R)), investigator benchmarking and budgeting (Medidata Grants Manager(TM)), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor(TM)), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave(R)). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
Integra LifeSciences Holdings Corporation (Nasdaq:IART) trading at $30.83 per share on trading volume of 71,749 shares.
In a press release out on October 28, Integra LifeSciences to Present at the Oppenheimer 20th Annual Healthcare Conference
PLAINSBORO, N.J., Oct 28, 2009 -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Oppenheimer 20th Annual Healthcare Conference.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Our products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.Integra-LS.com.
iGo, Inc. (Nasdaq: IGOI) trading at $1.37 per share on trading volume of 65,580 shares.
In a press release out on October 28, iGo(R) to Present at the 39th Annual TechAmerica AeA Classic Financial Conference
SCOTTSDALE, Ariz., Oct 28, 2009 -- iGo, Inc. (Nasdaq: IGOI), a leading provider of power management solutions, today announced that Michael D. Heil, CEO, and Darryl Baker, CFO, will be presenting at the 39th Annual TechAmerica AeA Classic Financial Conference. The conference is being held November 1 through November 3 at the Marriot San Diego Hotel & Marina in San Diego, CA.
About iGo, Inc.
iGo, Inc., based in Scottsdale, Arizona, is a leading provider of power management solutions, including eco-friendly chargers for laptop computers, netbooks and mobile electronic devices (e.g., mobile phones, PDAs, digital cameras, etc.). All of these chargers leverage iGo's intelligent tip technology, which significantly minimizes electronic waste by enabling one charger to power/charge hundreds of brands and thousands of models of mobile electronic devices through the use of interchangeable tips. iGo is also the creator of a new, innovative patent-pending power saving technology that automatically eliminates virtually all wasteful and expensive standby or "vampire" power that is generated from chargers that continue to draw electricity when a mobile electronic device no longer requires charging or is disconnected from the charger.
Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience.
Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at info@Xtremepicks.com Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ Back To Contact Center Solutions Homepage's Homepage ]
|
NextiraOne Obtains Cisco's Unified Contact Centre Enterprise ATP Status 
EXTOL Appoints Michael DeCosta Vice President of Sales
NEW Consolidating Infrastructures: IT's New Call to Business [white paper]
